miR-143 modifies insulin-mediated Akt activation and glucose homeostasis by downregulating the oxysterol-binding-protein-related protein 8 (ORP 8); therefore, the miR-143-ORP8 pathway acts as a critical therapeutic target for obesity-induced diabetes [82]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.